2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.

The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The practice guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of the AF Better Care pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian AF patients with single one stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the "coronavirus disease 2019" pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.

Azygous vein coil lowers defibrillation threshold in patients with high defibrillation threshold.

AIMS: Implantable cardioverter defibrillators (ICDs) reduce sudden death in patients at high risk. High defibrillation thresholds (DFTs) are not uncommon and may be the cause of failed defibrillation in patients with ICDs. Addition of a coil in the azygous vein posterior to the heart lowers the DFT in most patients by altering the electrical vector during defibrillation. This can be accomplished fairly easily and expeditiously using standard equipment in the laboratory. It also avoids the difficulties and complications associated with other methods such as the use of a subcutaneous array. METHODS AND RESULTS: This series of three cases illustrates the type of patients who may benefit from this technique. The addition of an azygous coil successfully lowered the DFT to <10 J in each case. A brief description of the technique used to implant the azygous coil follows. CONCLUSION: This simple and elegant solution can be highly useful as part of the armamentarium in tackling the problem of high DFTs.

Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation.

AIMS: Early recurrences of atrial arrhythmia after wide electrically isolating ablation for atrial fibrillation (AF) are well described, but the long-term risk of recurrence for patients with persistent and permanent AF has not been studied in detail. METHODS AND RESULTS Fifty-six consecutive patients [45 men (80.4%), age 55.9 +/- 8.7 years] with persistent [39(69.6%)] or permanent [17(30.4%)] AF were followed for 21.6 +/- 8.8 months after ablation. Atrial fibrillation duration prior to ablation was 6.4 +/- 5.6 years. Electrically isolating lesions encircling the left and right pulmonary veins (PVs) in pairs were created. After 1.5 +/- 0.7 procedures, 48 (85.7%) had sinus rhythm (SR) at 21.6 +/- 8.8 months of follow-up: achieved with 1 procedure in 27 (56.3%) and without anti-arrhythmics in 30 (62.5%). Atrial fibrillation recurrence was observed in 69.6% after the first and 46.4% after the last procedure. Of those with late recurrences (>90 days) following the last procedure, most [18 (69.2%)] did not have early recurrences. Pre-procedural AF duration (P = 0.007) and female gender (P = 0.005) were independent predictors of recurrence following the last procedure. CONCLUSION: Circumferential PV isolation is effective in most patients with persistent or permanent AF. However, repeat procedures are frequently required. Late recurrences are common and not precluded by the absence of early post-procedural arrhythmias.